Page last updated: 2024-09-04

ezetimibe and Muscle Disorders

ezetimibe has been researched along with Muscle Disorders in 30 studies

Research

Studies (30)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's18 (60.00)29.6817
2010's12 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hsiung, JT; Kleine, CE; Moradi, H; Park, C; Soohoo, M; Streja, DA; Streja, E1
Macchi, C; Magni, P; Morlotti, B; Ruscica, M; Sirtori, CR1
Graversen, CB; Larsen, ML; Schmidt, EB1
Cho, L; Colquhoun, D; Dent, R; Rocco, M; Rosenson, RS; Scott, R; Stroes, E; Sullivan, D; Wasserman, SM; Xue, A1
Ballantyne, CM; Catapano, A; Dent-Acosta, RE; Gouni-Berthold, I; Mancini, GB; Nissen, SE; Preiss, D; Rosenson, RS; Sattar, N; Scott, R; Stein, EA; Stroes, E; Thompson, PD; Wasserman, SM; Xue, A1
Fernandes, V; Pérez, A; Santos, MJ1
Bangalore, S; Hsue, PY; Waters, DD1
Ballantyne, CM; Brennan, DM; Bruckert, E; Ceška, R; Dent-Acosta, RE; Elliott, M; Gouni-Berthold, I; Lehman, SJ; Lepor, N; Nissen, SE; Preiss, D; Rosenson, RS; Sattar, N; Scott, R; Somaratne, R; Stein, EA; Stroes, E; Wasserman, SM1
Torjesen, I1
Tonstad, S1
Robinson, JG1
Brosteaux, C; Buclin, T; Kuntzer, T; Rodondi, N; Ruiz, J1
Lee, T1
Sacks, FM1
Fux, R; Gleiter, CH; Gundel, UF; Hartmann, R; Mörike, K1
Phillips, PS1
Cabello, A; Civeira-Murillo, F; Perez-Calvo, J1
McKenney, JM1
Poirier, P; Simard, C1
Havranek, JM; Phillips, PS; Warnke, GA; Wolfsen, AR1
Katz, U; Shoenfeld, Y; Szyper-Kravitz, M; Zimlichman, E1
Canora Lebrato, J; Frutos Pérez, B; Gutiérrez Gutiérrez, G; Zapatero Gaviria, A1
Ambrose, MS; Cote, H; DeNofrio, D; Duffy, GA; Patel, AR1
Shechter, M1
Abinader, EG1
Elisaf, MS; Florentin, M; Liberopoulos, EN1
Ballantyne, CM; Gimpelewicz, CR; Seper, C; Sirnes, PA; Stein, EA; Sussekov, A; Windler, E; Yigit, Z1
Bheemreddy, S; Foody, JM; Kashani, A; Mann, DL; Sallam, T; Wang, Y1

Reviews

10 review(s) available for ezetimibe and Muscle Disorders

ArticleYear
Precision Medicine and Personalized Management of Lipoprotein and Lipid Disorders in Chronic and End-Stage Kidney Disease.
    Seminars in nephrology, 2018, Volume: 38, Issue:4

    Topics: Anticholesteremic Agents; Cardiovascular Diseases; Dyslipidemias; Ezetimibe; Fenofibrate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Kidney Failure, Chronic; Muscular Diseases; Niacin; PCSK9 Inhibitors; Pharmacogenomic Variants; Practice Guidelines as Topic; Precision Medicine; Renal Dialysis; Renal Insufficiency, Chronic

2018
Risk identification and possible countermeasures for muscle adverse effects during statin therapy.
    European journal of internal medicine, 2015, Volume: 26, Issue:2

    Topics: Age Factors; Aged; Aged, 80 and over; Anticholesteremic Agents; Colesevelam Hydrochloride; Creatine Kinase; Drug Interactions; Drug Therapy, Combination; Dyslipidemias; Ezetimibe; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Male; Muscular Diseases; Myalgia; Rhabdomyolysis; Risk Assessment; Risk Factors; Rosuvastatin Calcium; Sex Factors; Vitamin D Deficiency

2015
[Statin intolerance].
    Ugeskrift for laeger, 2015, Aug-31, Volume: 177, Issue:36

    Topics: Anticholesteremic Agents; Cardiovascular Diseases; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Muscular Diseases; Risk Factors

2015
Statin-related myotoxicity.
    Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2016, Volume: 63, Issue:5

    Topics: Clinical Trials as Topic; Comorbidity; Creatine Kinase; Cytochrome P-450 CYP3A; Dietary Supplements; Disease Management; Disease Susceptibility; Drug Interactions; Drug Substitution; Exercise; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Male; Meta-Analysis as Topic; Muscular Diseases; Rhabdomyolysis; Risk Factors

2016
[Statin intolerance].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2017, Volume: 137, Issue:1

    Topics: Biological Products; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Muscular Diseases; PCSK9 Inhibitors; Risk Factors

2017
LDL reduction: how low should we go and is it safe?
    Current cardiology reports, 2008, Volume: 10, Issue:6

    Topics: Allylamine; Anticholesteremic Agents; Azetidines; Cholesterol, LDL; Colesevelam Hydrochloride; Coronary Artery Disease; Disease Progression; Drug Therapy, Combination; Ezetimibe; Fenofibrate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Muscular Diseases; Niacin; Risk Factors; Stroke

2008
[Statins and muscular side-effects].
    Revue medicale suisse, 2010, Mar-10, Volume: 6, Issue:239

    Topics: Age Factors; Aged, 80 and over; Algorithms; Anticholesteremic Agents; Azetidines; Biopsy; Cardiovascular Diseases; Creatine Kinase; Ezetimibe; Female; Humans; Life Style; Male; Muscle, Skeletal; Muscular Diseases; Myositis; Pain; Primary Prevention; Randomized Controlled Trials as Topic; Retrospective Studies; Rhabdomyolysis; Secondary Prevention; Sex Factors; Ubiquinone

2010
Pharmacologic options for aggressive low-density lipoprotein cholesterol lowering: benefits versus risks.
    The American journal of cardiology, 2005, Aug-22, Volume: 96, Issue:4A

    Topics: Allylamine; Anticholesteremic Agents; Atorvastatin; Azetidines; Cholesterol, LDL; Clinical Trials as Topic; Colesevelam Hydrochloride; Coronary Artery Disease; Drug Therapy, Combination; Ezetimibe; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Muscular Diseases; Niacin; Pyrimidines; Pyrroles; Rhabdomyolysis; Risk Factors; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Treatment Outcome

2005
Ezetimibe-associated adverse effects: what the clinician needs to know.
    International journal of clinical practice, 2008, Volume: 62, Issue:1

    Topics: Anticholesteremic Agents; Azetidines; Chemical and Drug Induced Liver Injury; Drug Interactions; Ezetimibe; Humans; Hypercholesterolemia; Muscular Diseases; Treatment Outcome

2008
Review of side-effect profile of combination ezetimibe and statin therapy in randomized clinical trials.
    The American journal of cardiology, 2008, Jun-01, Volume: 101, Issue:11

    Topics: Anticholesteremic Agents; Azetidines; Drug Therapy, Combination; Ezetimibe; Gastrointestinal Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Incidence; Lipids; Muscular Diseases; Randomized Controlled Trials as Topic; Risk Factors

2008

Trials

4 trial(s) available for ezetimibe and Muscle Disorders

ArticleYear
Clinical Profile of Statin Intolerance in the Phase 3 GAUSS-2 Study.
    Cardiovascular drugs and therapy, 2016, Volume: 30, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticholesteremic Agents; Cholesterol, LDL; Double-Blind Method; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Muscular Diseases; PCSK9 Inhibitors; Young Adult

2016
Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin-Intolerant Patients: Design of the Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin-Intolerant Subjects 3 (GAUSS-3) Trial.
    Clinical cardiology, 2016, Volume: 39, Issue:3

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticholesteremic Agents; Apolipoprotein B-100; Biomarkers; Cholesterol, LDL; Clinical Protocols; Double-Blind Method; Ezetimibe; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Muscular Diseases; PCSK9 Inhibitors; Proprotein Convertase 9; Research Design; Time Factors; Treatment Outcome

2016
Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial.
    JAMA, 2016, Apr-19, Volume: 315, Issue:15

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticholesteremic Agents; Atorvastatin; Biomarkers; Cholesterol, LDL; Creatine Kinase; Cross-Over Studies; Double-Blind Method; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Muscular Diseases; Myalgia; Myositis; Rhabdomyolysis; Time Factors

2016
Efficacy and tolerability of fluvastatin XL 80 mg alone, ezetimibe alone, and the combination of fluvastatin XL 80 mg with ezetimibe in patients with a history of muscle-related side effects with other statins.
    The American journal of cardiology, 2008, Feb-15, Volume: 101, Issue:4

    Topics: Anticholesteremic Agents; Azetidines; Cholesterol; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Ezetimibe; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lipoproteins; Male; Middle Aged; Muscular Diseases; Treatment Outcome; Triglycerides

2008

Other Studies

16 other study(ies) available for ezetimibe and Muscle Disorders

ArticleYear
PCSK9 Inhibitors for Statin Intolerance?
    JAMA, 2016, Apr-19, Volume: 315, Issue:15

    Topics: Antibodies, Monoclonal; Anticholesteremic Agents; Cholesterol, LDL; Ezetimibe; Female; Humans; Hypercholesterolemia; Male; Muscular Diseases

2016
Alternatives to statins in intolerant patients do lower cholesterol, study finds.
    BMJ (Clinical research ed.), 2016, Apr-05, Volume: 353

    Topics: Antibodies, Monoclonal; Anticholesteremic Agents; Cholesterol, LDL; Ezetimibe; Female; Humans; Hypercholesterolemia; Male; Muscular Diseases

2016
Ask the doctor. I have tried all of the statin drugs to lower my cholesterol, but each one has caused severe muscle pain. Are there any non-statin medications I could try using to lower my cholesterol?
    Harvard heart letter : from Harvard Medical School, 2010, Volume: 20, Issue:12

    Topics: Allylamine; Azetidines; Colesevelam Hydrochloride; Diet, Mediterranean; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypolipidemic Agents; Muscular Diseases; Niacin; Pain; Sitosterols

2010
Low-density lipoprotein lowering therapy: an analysis of the options.
    Journal of the American College of Cardiology, 2002, Dec-18, Volume: 40, Issue:12

    Topics: Anticholesteremic Agents; Azetidines; Cholesterol, LDL; Coronary Disease; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Muscular Diseases; Simvastatin

2002
Three new drugs for hyperlipidemia.
    The Medical letter on drugs and therapeutics, 2003, Mar-03, Volume: 45, Issue:1151

    Topics: Azetidines; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Ezetimibe; Humans; Hyperlipidemias; Hypolipidemic Agents; Intestinal Absorption; Lovastatin; Muscular Diseases; Niacin

2003
Ezetimibe and statin-associated myopathy.
    Annals of internal medicine, 2004, Apr-20, Volume: 140, Issue:8

    Topics: Adult; Azetidines; Creatine Kinase; Drug Interactions; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Muscular Diseases; Pain; Tendons

2004
Ezetimibe and statin-associated myopathy.
    Annals of internal medicine, 2004, Oct-19, Volume: 141, Issue:8

    Topics: Azetidines; Ezetimibe; Fatty Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Muscular Diseases; Oxidation-Reduction

2004
Worsening myopathy associated with ezetimibe in a patient with McArdle disease.
    QJM : monthly journal of the Association of Physicians, 2005, Volume: 98, Issue:6

    Topics: Anticholesteremic Agents; Azetidines; Ezetimibe; Glycogen Storage Disease Type V; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Muscular Diseases

2005
Ezetimibe-associated myopathy in monotherapy and in combination with a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
    The Canadian journal of cardiology, 2006, Volume: 22, Issue:2

    Topics: Adult; Anticholesteremic Agents; Azetidines; Creatine Kinase; Drug Interactions; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Muscle Weakness; Muscular Diseases; Pain

2006
Monotherapy with ezetimibe causing myopathy.
    The American journal of medicine, 2006, Volume: 119, Issue:3

    Topics: Anticholesteremic Agents; Azetidines; Ezetimibe; Female; Humans; Middle Aged; Muscular Diseases

2006
Intensive lipid-lowering therapy: obvious benefits, possible risks.
    The Israel Medical Association journal : IMAJ, 2006, Volume: 8, Issue:12

    Topics: Aged, 80 and over; Azetidines; Coronary Disease; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypolipidemic Agents; Muscular Diseases

2006
[Reversible myopathy due to ezetimibe].
    Medicina clinica, 2007, Feb-17, Volume: 128, Issue:6

    Topics: Anticholesteremic Agents; Azetidines; Ezetimibe; Female; Humans; Middle Aged; Muscular Diseases; Remission, Spontaneous

2007
Treatment of hypercholesterolemia with ezetimibe in cardiac transplant recipients.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2007, Volume: 26, Issue:3

    Topics: Adult; Aged; Anticholesteremic Agents; Azetidines; Ezetimibe; Female; Heart Transplantation; Humans; Hypercholesterolemia; Lipoproteins; Lipoproteins, LDL; Male; Middle Aged; Muscular Diseases; Pain

2007
Lipid-lowering therapy--benefits and risks.
    The Israel Medical Association journal : IMAJ, 2007, Volume: 9, Issue:2

    Topics: Azetidines; Coronary Disease; Drug Therapy, Combination; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypolipidemic Agents; Muscular Diseases; Risk Factors

2007
Lipid-lowering therapy--benefits and risks.
    The Israel Medical Association journal : IMAJ, 2007, Volume: 9, Issue:2

    Topics: Aged, 80 and over; Azetidines; Coronary Disease; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypolipidemic Agents; Muscular Diseases; Risk Factors

2007
I am a 74-year-old woman who walks every day and am not overweight. I had a stent put in two-and-a-half years ago. I have high blood pressure and cholesterol problems. I have tried all the statins and every one causes muscle pains. The pain gets so bad th
    Heart advisor, 2007, Volume: 10, Issue:6

    Topics: Aged; Allylamine; Anticholesteremic Agents; Azetidines; Colesevelam Hydrochloride; Diet; Exercise; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Muscular Diseases; Pain; Sleep Wake Disorders

2007